Skip to content

Author

Li-Ming Shang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review

Abstract Immune checkpoint inhibitors (ICIs) have transformed the treatment of hepatocellular carcinoma (HCC), but their clinical benefits are constrained by primary and acquired resistance and immune-related adverse events (irAEs). Understanding the biological processes underlying these outcomes is essential for impro...

Jin Li, Jin-Yi Zhou, Yue Yu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.